• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How we approach it: treatment options for hepatocellular carcinoma.

作者信息

Hernaez Ruben, El-Serag Hashem B

机构信息

Section of Gastroenterology and Hepatology, Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.

出版信息

Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.

DOI:10.1038/s41395-018-0008-9
PMID:29713029
Abstract
摘要

相似文献

1
How we approach it: treatment options for hepatocellular carcinoma.我们如何应对：肝细胞癌的治疗选择
Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.
2
TATI modality: A new perspective on the treatment of advanced hepatocellular carcinoma.经动脉化疗栓塞术（TATI）治疗方式：晚期肝细胞癌治疗的新视角。
J Cancer Res Ther. 2020 Sep;16(5):957-959. doi: 10.4103/jcrt.JCRT_850_20.
3
Hepatocellular carcinoma: status in the era of liver transplantation.肝细胞癌：肝移植时代的现状
J Okla State Med Assoc. 2009 Dec;102(12):355-61.
4
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肝细胞癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255. doi: 10.1093/annonc/mdy308.
5
Advances in Hepatocellular Carcinoma.肝细胞癌的进展
Clin Liver Dis. 2020 Nov;24(4):xiii-xiv. doi: 10.1016/j.cld.2020.08.014.
6
Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.经动脉化疗栓塞术后肝细胞癌出现罕见的早期致命性腹腔内破裂。
Dig Liver Dis. 2009 Feb;41(2):175-6. doi: 10.1016/j.dld.2008.08.005. Epub 2008 Oct 11.
7
What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?肝癌降期治疗的规则应该是什么？
J Gastrointest Cancer. 2020 Dec;51(4):1148-1151. doi: 10.1007/s12029-020-00490-0.
8
Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.肝细胞癌经动脉化疗栓塞术后出现大面积胃溃疡。
Gastrointest Endosc. 2006 Apr;63(4):718-20. doi: 10.1016/j.gie.2005.10.021.
9
Hepatocellular carcinoma in children.儿童肝细胞癌。
Clin Liver Dis. 2015 May;19(2):433-47. doi: 10.1016/j.cld.2015.01.010. Epub 2015 Feb 28.
10
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.索拉非尼联合经动脉化疗栓塞术治疗肝细胞癌。
Clin Adv Hematol Oncol. 2016 Aug;14(8):585-7.

引用本文的文献

1
Exploring the association between chemotherapy and prognosis among patients less than 50 years old with hepatocellular carcinoma: a retrospective cohort study based on the SEER database.探索年龄小于50岁的肝细胞癌患者化疗与预后之间的关联：一项基于监测、流行病学和最终结果（SEER）数据库的回顾性队列研究
Discov Oncol. 2025 May 7;16(1):682. doi: 10.1007/s12672-025-02490-7.
2
Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents.靶向铁死亡的天然化合物作为开发强效肝癌药物的一种有前景的方法。
Front Pharmacol. 2024 Apr 26;15:1399677. doi: 10.3389/fphar.2024.1399677. eCollection 2024.
3
A super-stable homogeneous Lipiodol-hydrophilic chemodrug formulation for treatment of hepatocellular carcinoma.
一种超稳定的均匀型 Lipiodol-亲水性化疗药物制剂，用于治疗肝细胞癌。
Theranostics. 2022 Jan 24;12(4):1769-1782. doi: 10.7150/thno.68456. eCollection 2022.
4
Rhenium Perrhenate (ReO) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells.高铼酸根（ReO）诱导肝癌细胞凋亡并降低其恶性表型。
Cells. 2022 Jan 17;11(2):305. doi: 10.3390/cells11020305.
5
LETM1 Knockdown Promotes Autophagy and Apoptosis Through AMP-Activated Protein Kinase Phosphorylation-Mediated Beclin-1/Bcl-2 Complex Dissociation in Hepatocellular Carcinoma.在肝癌中，LETM1基因敲低通过AMP激活的蛋白激酶磷酸化介导的Beclin-1/Bcl-2复合物解离促进自噬和凋亡。
Front Oncol. 2021 Jan 21;10:606790. doi: 10.3389/fonc.2020.606790. eCollection 2020.
6
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma.丙型肝炎相关肝细胞癌免疫反应基因多态性的临床意义
Front Microbiol. 2019 Mar 15;10:475. doi: 10.3389/fmicb.2019.00475. eCollection 2019.
7
Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival.立体定向体部放射治疗肝癌：实践模式、剂量选择和影响生存的因素。
Cancer Med. 2019 Mar;8(3):928-938. doi: 10.1002/cam4.1948. Epub 2019 Jan 31.
8
Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma.中医辅助西医共同治疗肝细胞癌。
Transl Gastroenterol Hepatol. 2018 Nov 26;3:97. doi: 10.21037/tgh.2018.11.05. eCollection 2018.